Program Summary
The Society for Immunotherapy of Cancer (SITC) will host the Summit on Immunomodulation of Antibody-drug Conjugates on Wednesday, June 26, 2024 from 11 a.m.–3:30 p.m. EDT. The virtual summit is a free, public event that features invited speakers, expert panel discussions, and attendee question and answer periods. The multi-stakeholder virtual summit will feature over 25 panelists representing academic research and industry around the world.
The SITC Summit on Immunomodulation of Antibody-drug Conjugates will highlight the latest translational and clinical research on antibody-drug conjugates (ADCs) and their impacts on the immune system, anti-tumor immunity, and the tumor microenvironment. Topics to be addressed at the summit include impact of ADCs on the immune system, clinical considerations surrounding ADCs, ADC combination therapies, and next-generation immunoconjugates.